Mortality rate of gestational trophoblastic neoplasia with a FIGO score of ≥13
- 30 September 2015
- journal article
- Published by Elsevier BV in American Journal of Obstetrics and Gynecology
- Vol. 214 (3), 390.e1-390.e8
- https://doi.org/10.1016/j.ajog.2015.09.083
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Placental site and epithelioid trophoblastic tumours: Diagnostic pitfallsGynecologic Oncology, 2013
- EMA/CO for High-Risk Gestational Trophoblastic Neoplasia: Good Outcomes With Induction Low-Dose Etoposide-Cisplatin and Genetic AnalysisJournal of Clinical Oncology, 2013
- Fatal cases of gestational trophoblastic neoplasia over four decades in the Netherlands: a retrospective cohort studyBJOG: An International Journal of Obstetrics and Gynaecology, 2012
- Contribution of referent pathologists to the quality of trophoblastic diseases diagnosisHuman Reproduction, 2011
- Gestational trophoblastic disease II: classification and management of gestational trophoblastic neoplasiaAmerican Journal of Obstetrics and Gynecology, 2010
- First epidemiological data from the French Trophoblastic Disease Reference CenterAmerican Journal of Obstetrics and Gynecology, 2007
- What is the best protocol of single-agent methotrexate chemotherapy in nonmetastatic or low-risk metastatic gestational trophoblastic tumors? A review of the evidenceGynecologic Oncology, 2006
- The new FIGO 2000 staging and risk factor scoring system for gestational trophoblastic disease: Description and critical assessmentInternational Journal of Gynecologic Cancer, 2001
- Etoposide and Cisplatin/Etoposide, Methotrexate, and Actinomycin D (EMA) Chemotherapy for Patients With High-Risk Gestational Trophoblastic Tumors Refractory to EMA/Cyclophosphamide and Vincristine Chemotherapy and Patients Presenting With Metastatic Placental Site Trophoblastic TumorsJournal of Clinical Oncology, 2000
- Treatment of high-risk gestational trophoblastic disease with chemotherapy combinations containing cisplatin and etoposideCancer, 1989